Indicating Direction and Angle for Cannulating of AV-fistula in Hemodialysis Patients

NCT01536548 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 83

Last updated 2020-10-05

No results posted yet for this study

Summary

Arteriovenous fistula is the preferred access for hemodialysis, and cannulation using a "button-hole" technique is increasingly recommended. By using the same two sites for cannulation there are reports of less risk of complications and less pain for the patient. However, button-hole cannulation can be difficult for the dialysis nurse, and failing cannulations can damage the AV fistula and increase patient discomfort. The investigators therefore will test whether a simple marking on the skin of the direction and angle of cannulation used in each specific patient could improve the probability of a successful and painfree cannulation.

Conditions

Interventions

PROCEDURE

Skin drawing

Mark direction and angle for cannulation with a pencil on the skin

PROCEDURE

No skin drawing

Standard practice; i.e. no marks on skin to help find correct direction and angle for introducing needles

Sponsors & Collaborators

  • St. Olavs Hospital

    collaborator OTHER
  • Haukeland University Hospital

    collaborator OTHER
  • Vestre Viken Hospital Trust

    collaborator OTHER
  • Sykehuset Innlandet HF

    collaborator OTHER
  • Kristiansund Hospital

    collaborator OTHER
  • Bodø sykehus

    collaborator UNKNOWN
  • University Hospital, Akershus

    collaborator OTHER
  • Norwegian University of Science and Technology

    lead OTHER

Principal Investigators

  • Stein Hallan, PhD MD · Norwegian University of Science and Technology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2012-04-30
Completion
2012-07-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01536548 on ClinicalTrials.gov